Theresa Lehner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Theresa Lehner has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Judith Maria Rollinger
University of Vienna
2 shared publications - Ammar Tahir
Department of Pharmaceutical Sciences, Division of Pharmacognosy, University of Vienna, Vienna, Austria
1 shared publication Benjamin Kirchweger
Department of Pharmacognosy, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090, Vienna, Austria
1 shared publication- Benjamin Kirchweger
Pharmaceutical Biology, Department of Pharmacy - Center for Drug Research, Ludwig-Maximilians-Universität München, Butenandtstraße 5, 81377 Munich, Germany
1 shared publication Dagmar Pretsch
Department of Pharmacognosy, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090, Vienna, Austria
1 shared publication- Dietmar Pum
Department of Nanobiotechnology, Institute of Biophysics, University of Natural Resources and Life Sciences Vienna, Muthgasse 11, 1190 Vienna, Austria
1 shared publication
Latest Publications
- Open Access
- 2 December 2021
- Published by MDPI AG in Applied Sciences
- Vol. 11 (23) , 11420
Workflow for Segmentation of Caenorhabditis elegans from Fluorescence Images for the Quantitation of Lipids
The small and transparent nematode Caenorhabditis elegans is increasingly employed for phenotypic in vivo chemical screens. The influence of compounds on worm body fat stores can be assayed with Nile red staining and imaging. Segmentation of C. elegans from fluorescence images is hereby a primary task. In this paper, we present an image-processing workflow that includes machine-learning-based segmentation of C. elegans directly from fluorescence images and quantifies their Nile red lipid-derived fluorescence. The segmentation is based on a J48 classifier using pixel entropies and is refined by size-thresholding. The accuracy of segmentation was >90% in our external validation. Binarization with a global threshold set to the brightness of the vehicle control group worms of each experiment allows a robust and reproducible quantification of worm fluorescence. The workflow is available as a script written in the macro language of imageJ, allowing the user additional manual control of classification results and custom specification settings for binarization. Our approach can be easily adapted to the requirements of other fluorescence image-based experiments with C. elegans.
- 2 December 2021
- Published by MDPI AG in Applied Sciences
- Vol. 11 (23) , 11420
Open AccessWorkflow for Segmentation of Caenorhabditis elegans from Fluorescence Images for the Quantitation of Lipids
The small and transparent nematode Caenorhabditis elegans is increasingly employed for phenotypic in vivo chemical screens. The influence of compounds on worm body fat stores can be assayed with Nile red staining and imaging. Segmentation of C. elegans from fluorescence images is hereby a primary task. In this paper, we present an image-processing workflow that includes machine-learning-based segmentation of C. elegans directly from fluorescence images and quantifies their Nile red lipid-derived fluorescence. The segmentation is based on a J48 classifier using pixel entropies and is refined by size-thresholding. The accuracy of segmentation was >90% in our external validation. Binarization with a global threshold set to the brightness of the vehicle control group worms of each experiment allows a robust and reproducible quantification of worm fluorescence. The workflow is available as a script written in the macro language of imageJ, allowing the user additional manual control of classification results and custom specification settings for binarization. Our approach can be easily adapted to the requirements of other fluorescence image-based experiments with C. elegans.
- Open Access
- 23 July 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-12
A robust and miniaturized screening platform to study natural products affecting metabolism and survival in Caenorhabditis elegans
In this study a robust, whole organism screening based onCaenorhabditis elegansis presented for the discovery of natural products (NP) with beneficial effects against obesity and age-related diseases. Several parameters of the elaborated workflow were optimized to be adapted for probing multicomponent mixtures combining knowledge from traditional medicine and NP chemistry by generating optimized small-scale extracts considering scarcity of the natural source, solubility issues, and potential assay interferences. The established miniaturized assay protocol allows for in vivo probing of small amounts of even complex samples (~ 1 mg) to test their ability to increase the nematodes’ survival time and the suppression of fat accumulation assessed by Nile red staining as hall marks of “healthy aging”. The workflow was applied on 24 herbal and fungal materials traditionally used against symptoms of the metabolic syndrome and revealed promising results for the extracts ofGardenia jasminoidesfruits and the sclerotia fromInonotus obliquus. Tested at 100 µg/mL they were able to significantly reduce the Nile red fluorescence and extend the 50% survival rate (DT50) compared to the control groups. This phenotype-directed in vivo approach opens up new horizons for the selection of natural starting materials and the investigation of their active principles as fast drug discovery tool with predictive value for human diseases.
- 23 July 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-12
Open AccessA robust and miniaturized screening platform to study natural products affecting metabolism and survival in Caenorhabditis elegans
In this study a robust, whole organism screening based onCaenorhabditis elegansis presented for the discovery of natural products (NP) with beneficial effects against obesity and age-related diseases. Several parameters of the elaborated workflow were optimized to be adapted for probing multicomponent mixtures combining knowledge from traditional medicine and NP chemistry by generating optimized small-scale extracts considering scarcity of the natural source, solubility issues, and potential assay interferences. The established miniaturized assay protocol allows for in vivo probing of small amounts of even complex samples (~ 1 mg) to test their ability to increase the nematodes’ survival time and the suppression of fat accumulation assessed by Nile red staining as hall marks of “healthy aging”. The workflow was applied on 24 herbal and fungal materials traditionally used against symptoms of the metabolic syndrome and revealed promising results for the extracts ofGardenia jasminoidesfruits and the sclerotia fromInonotus obliquus. Tested at 100 µg/mL they were able to significantly reduce the Nile red fluorescence and extend the 50% survival rate (DT50) compared to the control groups. This phenotype-directed in vivo approach opens up new horizons for the selection of natural starting materials and the investigation of their active principles as fast drug discovery tool with predictive value for human diseases.